BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada

NCT00272779 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1057

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: ATV
DRUG: RTV
DRUG: Tenofovi-Emtricitabine (TDF/FTC) tablet
DRUG: LPV

Sponsor

Bristol-Myers Squibb